Comparison of 99mTc-annexin A5 with 18F-FDG for the detection of atherosclerosis in ApoE−/− mice

  • Yan Zhao
  • Yuji Kuge
  • Songji Zhao
  • Koichi Morita
  • Masayuki Inubushi
  • H. William Strauss
  • Francis G. Blankenberg
  • Nagara Tamaki
Original Article

Abstract

Purpose

99mTc-annexin A5, a marker of ongoing apoptosis, and 18F-FDG, a marker of the increased metabolism of inflammatory cells, are supposed to be useful in the detection of metabolically active atheroma. This study reports a comparison of the intralesional distribution of these tracers in relation to lesion development in ApoE−/− mice.

Methods

Male ApoE−/− mice (n = 12–14/group) were maintained on a Western-type diet after the age of 5 weeks. At 25 weeks, 99mTc-annexin A5 or 18F-FDG was injected and the aortas were harvested for autoradiography (ARG) and Oil Red O staining. Regional radioactivity accumulation was compared in relation to the Oil Red O staining score (ranging from 0 to 3, a semiquantitative parameter for evaluating lesion development).

Results

Both 99mTc-annexin A5 and 18F-FDG showed preferential uptake into atherosclerotic lesions, with higher uptake levels for 18F-FDG (mean, 56.07 %ID×kg/m2) than for 99mTc-annexin A5 (mean, 10.38 %ID×kg/m2). The regional uptake levels of each tracer correlated with the Oil Red O staining score (r = 0.65, p < 0.05 for 99mTc-annexin A5; r = 0.56, p < 0.05 for 18F-FDG). The uptake ratios of advanced lesions (score >0.5) to early lesions (score <0.5) were significantly higher for 99mTc-annexin A5 than for 18F-FDG (f = 4.73, p = 0.03).

Conclusion

Both 99mTc-annexin A5 and 18F-FDG accumulate in atherosclerotic lesions and correlate with the severity of each lesion. The higher absolute uptake levels of 18F-FDG may be advantageous for lesion detection, whereas the preferential uptake of 99mTc-annexin A5 in advanced lesions may be a useful indicator of late-stage lesions or vulnerable plaque transformation.

Keywords

Atherosclerosis Apoptosis 99mTc-annexin A5 18F-FDG Apolipoprotein E-knockout mouse 

Notes

Acknowledgments

This research was supported in part by Grant-in-Aid for General Scientific Research and Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology of Japan and from the Japan Society for the Promotion of Science and by a research grant for cardiovascular diseases from the Ministry of Health, Labour and Welfare (15C-5 and 16C-8). The authors would like to thank the staff members of the Department of Nuclear Medicine and Central Institute of Isotope Science, Hokkaido University, and the Facility of Radiology, Hokkaido University Medical Hospital for supporting this work. We also thank Theseus Imaging Corporation for providing annexin A5.

References

  1. 1.
    Virmani R, Burke AP, Kolodgie FD, Farb A. Pathology of the thin-cap fibroatheroma: a type of vulnerable plaque. J Interv Cardiol 2003;16:267–72.PubMedCrossRefGoogle Scholar
  2. 2.
    Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000;20:1262–75.PubMedGoogle Scholar
  3. 3.
    Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801–9.PubMedCrossRefGoogle Scholar
  4. 4.
    Hamm CW, Bertrand M, Braunwald E. Acute coronary syndrome without ST elevation: implementation of new guidelines. Lancet 2001;358:1533–8.PubMedCrossRefGoogle Scholar
  5. 5.
    John RD, James FR, Tim DF, Peter LW. Targeting the vulnerable plaque: the evolving role of nuclear imaging. J Nucl Med 2005;12:234–46.Google Scholar
  6. 6.
    Nissen SE, Yock P. Intravascular ultrasound novel pathophysiological insights and current clinical applications. Circulation 2001;103:604–16.PubMedGoogle Scholar
  7. 7.
    Yabushita H, Bouma BE, Houser SL, Aretz HT, Jang IK, Schlendorf KH, et al. Characterization of human atherosclerosis by optical coherence tomography. Circulation 2002;106:1640–5.PubMedCrossRefGoogle Scholar
  8. 8.
    Stefanadis C, Diamantopoulos L, Vlachopoulos C, Tsiamis E, Dernellis J, Toutouzas K, et al. Thermal heterogeneity within human atherosclerotic coronary arteries detected in vivo: a new method of detection by application of a special thermography catheter. Circulation 1999;99:1965–71.PubMedGoogle Scholar
  9. 9.
    Waki H, Masuyama H, Mori H, Maeda T, Kitade K, Moriyasu K, et al. Ultrasonic tissue characterization of the atherosclerotic carotid artery: histological correlates or carotid integrated backscatter. Circ J 2003;67:1013–6.PubMedCrossRefGoogle Scholar
  10. 10.
    Schroeder S, Kopp AF, Baumbach A, Meisner C, Kuettner A, Georg C, et al. Noninvasive detection and evaluation of atherosclerotic coronary plaques with multislice computed tomography. J Am Coll Cardiol 2001;37:1430–5.PubMedCrossRefGoogle Scholar
  11. 11.
    Yuan C, Kerwin WS, Ferguson MS, Polissar N, Zhang S, Cai J, et al. Contrast-enhanced high resolution MRI for atherosclerotic carotid artery tissue characterization. J Magn Reson Imaging 2002;15:62–7.PubMedCrossRefGoogle Scholar
  12. 12.
    Trivedi RA, King-Im JM, Graves MJ, Cross JJ, Horsley J, Goddard MJ, et al. In vivo detection of macrophages in human carotid atheroma: temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI. Stroke 2004;35:1631–5.PubMedCrossRefGoogle Scholar
  13. 13.
    Blankenberg FG, Katsikis PD, Tait JF, Davis RE, Naumovski L, Ohtsuki K, et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci USA 1998;95:6349–54.PubMedCrossRefGoogle Scholar
  14. 14.
    Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999;340:115–26.PubMedCrossRefGoogle Scholar
  15. 15.
    Van der Wal AC, Becker AE, Van der Loss CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of dominant plaque morphology. Circulation 1994;89:36–44.PubMedGoogle Scholar
  16. 16.
    Geng YJ, Libby P. Evidence for apoptosis in advanced human atheroma. Am J Pathol 1995;147:251–66.PubMedGoogle Scholar
  17. 17.
    Lendon CI, Davies MJ, Born GV, Richardson PD. Atherosclerotic plaque caps are locally weakened when macrophage density is increased. Atherosclerosis 1991;87:87–90.PubMedCrossRefGoogle Scholar
  18. 18.
    Strauss HW, Grewal RK, Pandit-Taskar N. Molecular imaging in nuclear cardiology. Semin Nucl Med 2004;34:47–55.PubMedCrossRefGoogle Scholar
  19. 19.
    Tawakol A, Migrino RQ, Hoffmann U, Abbara S, Houser S, Gewirtz H, et al. Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J Nucl Cardiol 2005;12:294–301.PubMedCrossRefGoogle Scholar
  20. 20.
    Lederman RJ, Raylman RR, Fisher SJ, Kison PV, San H, Nabel EG. Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG). Nucl Med Commun 2001;22:747–53.PubMedCrossRefGoogle Scholar
  21. 21.
    Rudd JHF, Warburton EA, Fryer TD, Jones HA, Clark JC, Antoun N. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 2002;105:2708–11.PubMedCrossRefGoogle Scholar
  22. 22.
    Ogawa M, Ishino S, Mukai T, Asano D, Teramoto N, Watabe H. 18F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study. J Nucl Med 2004;45:1245–50.PubMedGoogle Scholar
  23. 23.
    Kolodgie FD, Petrov A, Virmani R, Narula N, Verjans JW, Weber DK. Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: a technique with potential for noninvasive imaging of vulnerable plaque. Circulation 2003;108:3134–9.PubMedCrossRefGoogle Scholar
  24. 24.
    Plump AS, Smith JD, Hayek T, Aalto-Setala K, Walsh A, Verstuyft JG, et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992;71:343–53.PubMedCrossRefGoogle Scholar
  25. 25.
    Zhang SH, Reddick RL, Piedrahita JA, Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992;258:468–71.PubMedCrossRefGoogle Scholar
  26. 26.
    Johnson JL, Jackson CL. Atherosclerotic plaque rupture in the apolipoprotein E knockout mouse. Atherosclerosis 2001;154:399–406.PubMedCrossRefGoogle Scholar
  27. 27.
    Williams H, Johnson JL, Carson KGS, Jackson CL. Characteristics of intact and ruptured atherosclerotic plaques in the brachiocephalic arteries of apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 2002;22:788–92.PubMedCrossRefGoogle Scholar
  28. 28.
    Johnson J, Carson K, Williams H, Karanam S, Newby A, Angelini G, et al. Plaque rupture after short periods of fat feeding in the apolipoprotein E-knockout mouse: model characterization and effects of pravastatin treatment. Circulation 2005;111:1422–30.PubMedCrossRefGoogle Scholar
  29. 29.
    Coleman R, Hayek T, Keidar S, Aviram M. A mouse model for human atherosclerosis: long-term histopathological study of lesion development in the aortic arch of apolipoprotein E-deficient (E0) mice. Acta Histochem 2006;108:415–24.PubMedCrossRefGoogle Scholar
  30. 30.
    Wood BL, Gibson DF, Tait JF. Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations. Blood 1996;88:1873–80.PubMedGoogle Scholar
  31. 31.
    Tait JF, Brown DS, Gibson DF, Blankenberg FG, Strauss HW. Development and characterization of annexin V mutants with endogenous chelation sites for 99mTc. Bioconjug Chem 2000;11:918–25.PubMedCrossRefGoogle Scholar
  32. 32.
    Mochizuki T, Kuge Y, Zhao S, Tsukamoto E, Hosokawa M, Strauss HW, et al. Detection of apoptotic tumor response in vivo after a single dose of chemotherapy with 99mTc-annexin V. J Nucl Med 2003;44:92–7.PubMedGoogle Scholar
  33. 33.
    Brown RS, Leung JY, Fisher SJ, Frey KA, Ethier SP, Wahl RL. Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma. I. Are inflammatory cells important? J Nucl Med 1995;36:1854–61.PubMedGoogle Scholar
  34. 34.
    Zhao S, Kuge Y, Mochizuki T, Takahashi T, Nakada K, Sato M, et al. Biologic correlates of intratumoral heterogeneity in 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor. J Nucl Med 2005;46:794–9.PubMedGoogle Scholar
  35. 35.
    Johnson LL, Schofield L, Donahay T, Narula N, Narula J. 99mTc-annexin V imaging for in vivo detection of atherosclerotic lesions in porcine coronary arteries. J Nucl Med 2005;46:1186–93.PubMedGoogle Scholar
  36. 36.
    Kietselaer BL, Reutelingsperger CP, Heidendal GA, Daemen MJ, Mess WH, Hofstra L, et al. Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis. N Engl J Med 2004;350:1472–3.PubMedCrossRefGoogle Scholar
  37. 37.
    Strauss HW, Mari C, Patt BE, Ghazarossian V. Intravascular radiation detectors for the detection of vulnerable atheroma. J Am Coll Cardiol 2006;47(8 Suppl):C97–100.PubMedCrossRefGoogle Scholar
  38. 38.
    Isobe S, Tsimikas S, Zhou J, Fujimoto S, Sarai M, Branks MJ, et al. Noninvasive imaging of atherosclerotic lesions in apolipoprotein E-deficient and low-density-lipoprotein receptor-deficient mice with annexin A5. J Nucl Med 2006;47:1497–505.PubMedGoogle Scholar
  39. 39.
    Grierson JR, Yagle KJ, Eary JF, Tait JF, Gibson DF, Lewellen B, et al. Production of [F-18]fluoroannexin for imaging apoptosis with PET. Bioconjug Chem 2004;15:373–9.PubMedCrossRefGoogle Scholar
  40. 40.
    Smith-Jones PM, Afroze A, Zanzonico P, Tait J, Larson SM, Strauss HW. 68Ga labeling of annexin-V: comparison to 99mTc-annexin-V and 67Ga-annexin. J Nucl Med 2003;44(5 Suppl):49P–50P.Google Scholar
  41. 41.
    Zhang Z, Machac J, Helft G, Worthley SG, Tang C, Zaman AG, et al. Non-invasive imaging of atherosclerotic plaque macrophage in a rabbit model with F-18 FDG PET: a histopathological correlation. BMC Nucl Med 2006;6:3.PubMedCrossRefGoogle Scholar
  42. 42.
    Tawakol A, Migrino RQ, Bashian GG, Bedri S, Vermylen D, Cury RC, et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 2006;48:1818–24.PubMedCrossRefGoogle Scholar
  43. 43.
    Rosenfeld ME, Polinsky P, Virmani R, Kauser K, Rubanyi G, Schwartz SM. Advanced atehrosclerotic lesions in the innominate artery of the ApoE knockout mouse. Arterioscler Thromb Vasc Biol 2000;20:2587–92.PubMedGoogle Scholar
  44. 44.
    Schreyer SA, Vick C, Lystig TC, Mystkowski P, LeBoeuf RC. LDL receptor but not apoliporotein E deficiency increases diet-induced obesity and diabetes in mice. Am J Physiol Endocrinol Metab 2002 282:E207–14.PubMedGoogle Scholar
  45. 45.
    Ohtsuki K, Hayase M, Akashi K, Kopiwoda S, Strauss HW. Detection of monocyte chemoattractant protein-1 receptor expression in experimental atherosclerotic lesions: an autoradiographic study. Circulation 2001;104:203–8.PubMedGoogle Scholar
  46. 46.
    Qin G, Zhang Y, Cao W, An R, Gao Z, Li G, et al. Molecular imaging of atherosclerotic plaques with technetium-99m-labelled antisense oligonucleotides. Eur J Nucl Med Mol Imaging 2005;32:6–14.PubMedCrossRefGoogle Scholar
  47. 47.
    Hartung D, Sarai M, Petrov A, Kolodgie F, Narula N, Verjans J, et al. Resolution of apoptosis in atherosclerotic plaque by dietary modification and statin therapy. J Nucl Med 2005;46:2051–6.PubMedGoogle Scholar
  48. 48.
    Johnson JL, Fritsche-Danielson R, Behrendt M, Westin-Eriksson A, Wennbo H, Herslof M, et al. Effect of broad-spectrum matrix metalloproteinase inhibition on atherosclerotic plaque stability. Cardiovasc Res 2006;71:586–95.PubMedCrossRefGoogle Scholar
  49. 49.
    Mazzolai L, Duchosal MA, Korber M, Bouzourene K, Aubert JF, Hao H, et al. Endogenous angiotensin II induces atherosclerotic plaque vulnerability and elicits a Th1 response in ApoE−/− mice. Hypertension 2004;44:277–82.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Yan Zhao
    • 1
  • Yuji Kuge
    • 2
    • 3
    • 4
  • Songji Zhao
    • 1
    • 2
  • Koichi Morita
    • 1
  • Masayuki Inubushi
    • 3
  • H. William Strauss
    • 5
  • Francis G. Blankenberg
    • 6
  • Nagara Tamaki
    • 1
  1. 1.Department of Nuclear Medicine, Graduate School of MedicineHokkaido UniversitySapporoJapan
  2. 2.Department of Tracer Kinetics, Graduate School of MedicineHokkaido UniversitySapporoJapan
  3. 3.Department of Molecular Imaging, Graduate School of MedicineHokkaido UniversitySapporoJapan
  4. 4.Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical SciencesKyoto UniversityKyotoJapan
  5. 5.Department of Nuclear MedicineMemorial Sloan-Kettering Cancer CenterNew YorkUSA
  6. 6.Department of Pediatric RadiologyStanford University School of MedicinePalo AltoUSA

Personalised recommendations